General Proximity | RoundOS

Weekly digest by email

Loading companies…

General Proximity | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
May 4, 2026	Strategic	$20M	Daewoong Pharmaceutical — Role not disclosedFreeMind Investments — Role not disclosed

Investors

Daewoong PharmaceuticalStrategic FreeMind InvestmentsStrategic

Coverage

May 4, 2026General Proximity · Strategic

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

generalproximity.bio ↗